Evaluation of 30-day mortality rate following intravenous systemic anticancer therapy: a retrospective analysis
Monitoring 30-day mortality post-SACT is essential for improving oncological care quality. Identifying and addressing modifiable risk factors and carefully selecting patients for modern oncological treatments can help reduce mortality rates. Further prospective studies are warranted to explore the impact of immunotherapy on short-term mortality in diverse cancer populations.
Authors
- Nuriye Özdemir (ORCID: https://orcid.org/0000-0002-9235-9592)
- Aytuğ Üner (ORCID: https://orcid.org/0000-0003-3836-3854)
- Orhun Akdoğan (ORCID: https://orcid.org/0000-0003-0212-1191)
- Nazan Günel (ORCID: https://orcid.org/0000-0003-3152-6008)
- Ahmet Özet (ORCID: https://orcid.org/0000-0001-8731-9636)
- Osman Sütçüoğlu (ORCID: https://orcid.org/0000-0003-3835-2741)
- Taha Enes Çetin (ORCID: https://orcid.org/0000-0003-2125-5881)
- Ozan Yazıcı (ORCID: https://orcid.org/0000-0003-0038-3569)
- Gozde Savas
Institutions
- Gazi University (TR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12885-025-14513-1
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Gazi Üniversitesi